1-3 of 3
Francesca Pellicano, PhD
Close
Sort by
Journal Articles

p53 and c-Myc Are Critical Signaling Hubs That Maintain Chronic Myeloid Leukemia

Sheela A Abraham, PhD, Lisa Hopcroft, PhD, Emma Carrick, PhD, Andrew Williamson, PhD, Andrew Pierce, PhD, Jennifer Cassels, Francesca Pellicano, PhD, Anthony Whetton, Tessa L Holyoake, PhD, MB, ChB, FRCP, FRCPath, FRSE
Journal: Blood
Blood (2013) 122 (21): 1465.
https://doi.org/10.1182/blood.V122.21.1465.1465
Published: 2013
Journal Articles

BMS-214662 Eliminates Quiescent and Proliferating Acute Myeloid Leukemia Cells through Activation of Protein Kinase Cβ and Enhances the Efficacy of Cytosine Arabinoside

Francesca Pellicano, PhD, Amy Sinclair, BSc, MSc, Alan Hair, BSc, PhD, Tessa L. Holyoake, PhD, FRCP, FRCPath, Mhairi Copland, PhD, BSc, MRCP, FRCPath
Journal: Blood
Blood (2010) 116 (21): 2167.
https://doi.org/10.1182/blood.V116.21.2167.2167
Published: 2010
Journal Articles

Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors.

Daniela Cilloni, MD, PhD, Francesca Pellicano, PhD, Vignir G Helgason, PhD, Cristina Panuzzo, PhD, Francesca Messa, PhD, Brian J Huntly, MD, Elaine Allan, PhD, Francesca Arruga, PhD, Enrico Bracco, PhD, Giuseppe Saglio, MD, Tessa L Holyoake, MD
Journal: Blood
Blood (2009) 114 (22): 187.
https://doi.org/10.1182/blood.V114.22.187.187
Published: 2009